What is the Fiscal Year for Spruce Biosciences?

Headquarters

South San Francisco, California

Industry

Biotechnology Research

Stock Symbol

SPRB

Website

Description

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. At the heart of everything we do is our commitment to patients and their families. They inspire us to go beyond incremental progress to develop transformative therapies born from thoughtful science that leads to meaningful changes in their lives. Our initial focus is developing tralesinidase alfa enzyme replacement therapy (TA-ERT) for the treatment of mucopolysaccharidoses type IIIB (MPS IIIB), or Sanfilippo Syndrome Type B, a devastating pediatric neurodegenerative disorder for which there are no FDA-approved therapies. Spruce reserves the right to hide or report content and block users who do not follow the Community Guidelines or the rules of the applicable social media platform. This includes content that is offensive, defamatory, harassing, discriminatory, unlawful, threatening, spam or otherwise inappropriate; infringes on intellectual property rights; shares confidential, sensitive, non-public or personal information; or could harm Spruce, its community or others.